FibroBiologics, Inc., 2026-06-29
An SEC Form D private-offering notice from Houston, TX, a $3,000,000 filer-stated offering target in Biotech. Filed 2026-06-29. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing fibroblast cell-based therapies for chronic diseases, including multiple sclerosis, degenerative disc disease and wound healing.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- PieTech, Inc., 2026-06-30, $23.7M, Houston, TX
- Recombinant Diagnostics LLC, 2026-06-30, Aventura, FL
- GlobalXBPay Inc, 2026-06-29, $100K, Dallas, TX
- Conexeu Sciences Inc., 2026-06-30, $86K, Reno, NV
- Generations Continuum Group, LLC, 2026-06-29, $18M, Port Aransas, TX
- SonoThera, Inc., 2026-06-30, $125.5M, South San Francisco, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.